103 related articles for article (PubMed ID: 7993077)
1. Use of a flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compounds.
Bartholomeusz A; Tomlinson E; Wright PJ; Birch C; Locarnini S; Weigold H; Marcuccio S; Holan G
Antiviral Res; 1994 Aug; 24(4):341-50. PubMed ID: 7993077
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
Zandi K; Bassit L; Amblard F; Cox BD; Hassandarvish P; Moghaddam E; Yueh A; Libanio Rodrigues GO; Passos I; Costa VV; AbuBakar S; Zhou L; Kohler J; Teixeira MM; Schinazi RF
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
[TBL] [Abstract][Full Text] [Related]
3. Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase.
Cannalire R; Tarantino D; Astolfi A; Barreca ML; Sabatini S; Massari S; Tabarrini O; Milani M; Querat G; Mastrangelo E; Manfroni G; Cecchetti V
Eur J Med Chem; 2018 Jan; 143():1667-1676. PubMed ID: 29137867
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
[TBL] [Abstract][Full Text] [Related]
5. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R
Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551
[TBL] [Abstract][Full Text] [Related]
6. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
7. Triaryl pyrazoline compound inhibits flavivirus RNA replication.
Puig-Basagoiti F; Tilgner M; Forshey BM; Philpott SM; Espina NG; Wentworth DE; Goebel SJ; Masters PS; Falgout B; Ren P; Ferguson DM; Shi PY
Antimicrob Agents Chemother; 2006 Apr; 50(4):1320-9. PubMed ID: 16569847
[TBL] [Abstract][Full Text] [Related]
8. The antimicrobial peptide HS-1 inhibits dengue virus infection.
Monteiro JMC; Oliveira MD; Dias RS; Nacif-Marçal L; Feio RN; Ferreira SO; Oliveira LL; Silva CC; Paula SO
Virology; 2018 Jan; 514():79-87. PubMed ID: 29153860
[TBL] [Abstract][Full Text] [Related]
9. Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor.
Tarantino D; Cannalire R; Mastrangelo E; Croci R; Querat G; Barreca ML; Bolognesi M; Manfroni G; Cecchetti V; Milani M
Antiviral Res; 2016 Oct; 134():226-235. PubMed ID: 27649989
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
Lee E; Pavy M; Young N; Freeman C; Lobigs M
Antiviral Res; 2006 Jan; 69(1):31-8. PubMed ID: 16309754
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of lanatoside C against dengue virus infection.
Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ
Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726
[TBL] [Abstract][Full Text] [Related]
12. Anti-flavivirus activity of polyoxometalate.
Qi Y; Han L; Qi Y; Jin X; Zhang B; Niu J; Zhong J; Xu Y
Antiviral Res; 2020 Jul; 179():104813. PubMed ID: 32376449
[TBL] [Abstract][Full Text] [Related]
13. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing of quinine as antiviral against dengue virus infection.
Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
[TBL] [Abstract][Full Text] [Related]
15. Flaviviruses are sensitive to inhibition of thymidine synthesis pathways.
Fischer MA; Smith JL; Shum D; Stein DA; Parkins C; Bhinder B; Radu C; Hirsch AJ; Djaballah H; Nelson JA; Früh K
J Virol; 2013 Sep; 87(17):9411-9. PubMed ID: 23824813
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase.
Shimizu H; Saito A; Mikuni J; Nakayama EE; Koyama H; Honma T; Shirouzu M; Sekine SI; Shioda T
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007894. PubMed ID: 31738758
[TBL] [Abstract][Full Text] [Related]
17. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
Chew MF; Tham HW; Rajik M; Sharifah SH
J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692
[TBL] [Abstract][Full Text] [Related]
18. Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses.
Carocci M; Yang PL
Antiviral Res; 2016 Apr; 128():57-62. PubMed ID: 26872864
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
20. Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein.
Meutiawati F; Bezemer B; Strating JRPM; Overheul GJ; Žusinaite E; van Kuppeveld FJM; van Cleef KWR; van Rij RP
Antiviral Res; 2018 Sep; 157():68-79. PubMed ID: 29981375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
